BI 655066

Showing 1 posts of 1 posts found.

abbvie

AbbVie pays $595m upfront for experimental Boehringer psoriasis drug

March 8, 2016
Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, BI 655066, Boehringer Ingelheim, psoriasis

AbbVie is betting big on the future of an experimental psoriasis drug, paying $595m upfront for the rights to Boehringer …

The Gateway to Local Adoption Series

Latest content